
The study aimed to investigate associations of attainment of a modified SRI (mSRI) version with key clinical outcomes in SLE patients with up to 5 years of follow‐up. The study used data from a large multicenter, longitudinal SLE cohort in which patients received standard of care. The study included 2,060 patients, with a median baseline SLEDAI‐2K score of 8. An mSRI response was attained by 56% of patients at 1 year, with similar responder rates seen at subsequent annual time points. In SLE patients with active disease receiving standard of care, mSRI attainment predicts favourable outcomes over long‐term follow‐up, supporting the clinical meaningfulness of SRI attainment as an SLE trial endpoint.
Like
Save
Share